Pasithea Therapeutics Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KTTA research report →
Companywww.pasithea.com
Pasithea Therapeutics Corp. , a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine.
- CEO
- Tiago Reis Marques
- IPO
- 2021
- Employees
- 4
- HQ
- Miami Beach, FL, US
Price Chart
Valuation
- Market Cap
- $5.37M
- P/E
- -0.89
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 2355.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -0.14%
- ROIC
- -0.04%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-20,427,683 · -46.91%
- EPS
- $-2.91 · 77.07%
- Op Income
- $-20,857,295
- FCF YoY
- -109150.95%
Performance & Tape
- 52W High
- $2.06
- 52W Low
- $0.28
- 50D MA
- $0.77
- 200D MA
- $0.82
- Beta
- 0.22
- Avg Volume
- 419.62K
Get TickerSpark's AI analysis on KTTA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Marques Tiago | other | 1,756,069 |
| May 1, 26 | STEINMAN LAWRENCE | other | 152,783 |
| May 1, 26 | Dumesnil Simon | other | 152,783 |
| May 1, 26 | Schneiderman Daniel H | other | 1,129,323 |
| May 1, 26 | Krishnan Kartik | other | 1,129,323 |
| May 1, 26 | Leahy Emer | other | 152,783 |
| May 1, 26 | Novak Alfred J | other | 152,783 |
| May 1, 26 | Krishnan Kartik | other | 0 |
| Apr 9, 26 | Coastlands Capital LP | other | 0 |
| Apr 9, 26 | Coastlands Capital LP | other | 11,233,334 |
Our KTTA Coverage
We haven't published any research on KTTA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KTTA Report →